IF by specialty › Infectious Diseases
Journal of Antimicrobial Chemotherapy — Impact Factor
The 2025 Impact Factor of Journal of Antimicrobial Chemotherapy is 4.1 (quartile not confirmed; subscription or hybrid).
- Impact Factor
- 4.1 JCR 2025
- JCR category
- Infectious Diseases
- Quartile
- quartile not confirmed
- Publisher
- Oxford University Press (BSAC)
- Open access
- subscription or hybrid
- IF source
- academic.oup.com
Position within the field
Ranked 21 of the 42 journals in Infectious Diseases on this site (top 50%).
Infectious Diseases journals with a similar Impact Factor
- Antimicrobial Agents and Chemotherapy IF 4.2
- The Journal of Infectious Diseases IF 4.1
- Infectious Disease Clinics of North America IF 4.1
- Infection IF 3.9
- Open Forum Infectious Diseases IF 3.8
- Journal of Microbiology, Immunology and Infection IF 3.8
About this value
The Journal Impact Factor of Journal of Antimicrobial Chemotherapy (JCR 2025, released June 2026) is 4.1. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Infectious Diseases.